Home > Category > Signaling Pathways > Cytoskeletal Signaling > Integrin > Erlizumab (Synonyms: rhuMAb;Anti-Integrin b2 / ITGB2 / CD18)

Erlizumab (Synonyms: rhuMAb;Anti-Integrin b2 / ITGB2 / CD18)

ChemLeader 95+%

Catalog No：CLA1211 CAS No.：211323-03-4 MDLNo： Formula： MW：

Collect Share

Size	Availability	Price(USD)	VIP Price (USD)	Quantity
1 mg	3-5days	$1300.00	Visible after login	- +
5 mg	3-5days	$4000.00	Visible after login	- +
10 mg	3-5days	$7600.00	Visible after login	- +
50 mg	3-5days	$38000.00	Visible after login	- +

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry Add To Cart

Product Overview
Related documents
Product details
Related literature

Product Overview

Product Name	Erlizumab (Synonyms: rhuMAb;Anti-Integrin b2 / ITGB2 / CD18)
CAS	211323-03-4
Storage condition	Store at 2 to 8 °C for 1-2 weeks. Store at -20 °C for 12 months. Store at -80 °C for long term storage. Use a manual defrost freezer and avoid repeated freeze-thaw cycles, away from light.

Product details

Erlizumab (anti-Integrin b2 / ITGB2 / CD18) is a humanized monoclonal antibody targeted against Integrin beta-2 and used as a therapy for hemorrhagic shock. MW: 146.66 kD.

Related literature

Sorry, there is no relevant literature

Sorry, no related items

History

CLA1211

Erlizumab (Synonyms: rhuMAb;Anti-Integrin b2 / ITGB2 / CD18)

211323-03-4 95+%